Legal Representation
Attorney
Christina M. Licursi
USPTO Deadlines
Next Deadline
158 days remaining
NOA E-Mailed - SOU Required
Due Date
May 27, 2026
Extension Available
Until November 27, 2026
Application History
29 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 27, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 26, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 26, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 26, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 27, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 1, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 1, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 7, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 6, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 6, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 6, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 5, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 5, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 5, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 20, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 20, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 20, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 19, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jul 19, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Jun 28, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 28, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 28, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 27, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 29, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 29, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Feb 29, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 16, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 30, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for use in the treatment and diagnosis of cancer; therapeutic pharmaceuticals for use in the treatment and diagnosis of cancer; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids and tissue samples for the treatment and diagnosis of cancer; pharmaceutical preparations comprised of medical diagnostic reagents and assays for testing of bodily fluids and tissue samples for the treatment and diagnosis of cancer
Class 042
Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology, and pharmaceuticals; drug discovery platform services
Classification
International Classes
005
042